Literature DB >> 6348636

Infectivity virulence and immunogenicity of Anaplasma centrale live blood vaccine.

F T Potgieter, L Van Rensburg.   

Abstract

Cross-bred Bos taurus calves, aged between 6 and 8 months, were inoculated with the Onderstepoort Anaplasma centrale live blood vaccine. One group of 15 calves were inoculated once only, while a 2nd group of 15 were revaccinated 6 months later. All the animals were challenged with approximately 1 X 10(10) Anaplasma marginale parasites of a known virulent strain 8 months after the first vaccination. The results of blood smear examination and the card agglutination test indicated that only 20 out of 30 animals vaccinated contracted A. centrale infections after the first attempt, and 3 out of 5 after the second. The vaccine conferred only partial immunity to challenge with a virulent A. marginale strain.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6348636

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN： 0030-2465            Impact factor:   1.792


  9 in total

1.  Indigenous and crossbred cattle--a comparison of resistance to ticks and implications for their strategic control in Zimbabwe.

Authors:  B H Fivaz; D T de Waal; K Lander
Journal:  Trop Anim Health Prod       Date:  1992-05       Impact factor: 1.559

2.  Expression and immune recognition of the conserved MSP4 outer membrane protein of Anaplasma marginale.

Authors:  S M Oberle; G H Palmer; A F Barbet
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

3.  Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.

Authors:  Michael J Dark; Basima Al-Khedery; Anthony F Barbet
Journal:  Vaccine       Date:  2011-05-17       Impact factor: 3.641

4.  Tick-borne haemoparasites in African buffalo (Syncerus caffer) from two wildlife areas in Northern Botswana.

Authors:  Dewald Eygelaar; Ferran Jori; Mokganedi Mokopasetso; Kgomotso P Sibeko; Nicola E Collins; Ilse Vorster; Milana Troskie; Marinda C Oosthuizen
Journal:  Parasit Vectors       Date:  2015-01-15       Impact factor: 3.876

5.  Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.

Authors:  Deirdre R Ducken; Wendy C Brown; Debra C Alperin; Kelly A Brayton; Kathryn E Reif; Joshua E Turse; Guy H Palmer; Susan M Noh
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

Review 6.  Detection and Characterisation of Anaplasma marginale and A. centrale in South Africa.

Authors:  Paidashe Hove; Zamantungwa T H Khumalo; Mamohale E Chaisi; Marinda C Oosthuizen; Kelly A Brayton; Nicola E Collins
Journal:  Vet Sci       Date:  2018-03-03

7.  Comparison of three nucleic acid-based tests for detecting <i>Anaplasma marginale</i> and <i>Anaplasma centrale</i> in cattle.

Authors:  Mamohale E Chaisi; Janine R Baxter; Paidashe Hove; Chimvwele N Choopa; Marinda C Oosthuizen; Kelly A Brayton; Zamantungwa T H Khumalo; Awelani M Mutshembele; Moses S Mtshali; Nicola E Collins
Journal:  Onderstepoort J Vet Res       Date:  2017-01-23       Impact factor: 1.792

8.  Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle.

Authors:  María E Primo; Carolina S Thompson; Beatriz S Valentini; Macarena Sarli; María B Novoa; Atilio J Mangold; Susana T de Echaide
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

9.  A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.

Authors:  Macarena Sarli; María B Novoa; Matilde N Mazzucco; Marcelo L Signorini; Ignacio E Echaide; Susana T de Echaide; María E Primo
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.